Is #CYP2A6 among your favorite genes? Want to learn more about this #pharmacogene? Check out PharmVar's latest GeneFocus article at ascpt.onlinelibrary.wiley.co…
2/2 Several changes were made to conform nomenclature to PharmVar rules and standards which are detailed in the Read Me and Change Log documents at pharmvar.org/gene/NAT2. The “Look-up” table under “More Documents” facilitates easy conversion of the old to the new nomenclature.
Rethink using c.1236G>A as a tagSNP!
Updated DPYD HapB3 haplotype structure and implications for pharmacogenomic testing - Turner - Clinical and Translational Science - Wiley Online Library ascpt.onlinelibrary.wiley.co…
#PharmVar has a new look! Upon user request rsIDs are now provided along variant positions and impact. rsIDs link out directly to dbSNP while clicking on variant positions will open the variant window detailing SNP positions across different reference sequences.
PharmVar retweeted
The ClinGen Pharmacogenomics Working Group survey closes this Friday, June 30 - If you haven’t already, please share your thoughts with us at stanforduniversity.qualtrics…
1/ #PharmVar announces major content changes. The decision to retire several CYP genes is based on a points-based rating system allowing us to prioritize genes of interest. More detailed information will be posted under the PharmVar GENES tab once changes take effect May 12, 2023
3/ PharmVar will also remove records for the following ‘legacy’ genes: CYP4A11, CYP4A22, CYP4B1, CYP17A1, CYP19A1, CYP21A2, CYP26A1, TBXAS1, and PTGIS. Other databases such as ClinGen and/or ClinVar should be consulted for variation annotations.
Please consider taking this important survey to help the ClinGen PGx working group
We'd like to hear your thoughts on pharmacogenomics! ClinGen's PGxWG launched a survey to assess the needs of the clinical genetics community. Please share your thoughts on criteria, terminology, actionability, barriers, & more: stanforduniversity.qualtrics… #ACMGMtg23
2/2
c.1026+12G>A removed from #CYP3A4*8, *9, *15, *16, *18, *19, *23, *24, and *28
Many rare alleles are now fully characterized and have an evidence level of ‘Definitive’
Addition of *38, a new star allele




